Treatment And Inhibition Of Inflammatory Lung Diseases In Patients Having Risk Alleles In The Genes Encoding Il33 And Il1Rl1 - EP3957752
The patent EP3957752 was granted to Regeneron Pharmaceuticals on Aug 20, 2025. The application was originally filed on Mar 20, 2018. The patent is currently recorded with a legal status of "Granted".
EP3957752
- Filing Date
- Mar 20, 2018
- Status
- Granted
- Grant Date
- Aug 20, 2025
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents